Clinical trial Recruiting at 5 sites Observational Ages 50 and up

Identifying cardiac amyloidosis in older adults with lumbar spinal stenosis

Official title: Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis

Run by Columbia University · NCT06034405 · Data updated 2026-11-12

This study is trying to find out if older adults who have had surgery for lumbar spinal stenosis also have a heart condition called transthyretin cardiac amyloidosis by looking at their spinal tissue and using advanced technology.

More Cardiac Amyloidosis trials

Quick facts

Study typeObservational
Ages50 Years and up
SexAll
Enrollment1663 (estimated)
SponsorColumbia University
Academic / other
Locations6 sites (Beverly Hills, California and 5 other locations)
StatusRecruiting
StartedSeptember 19, 2023
Main results expectedMay 2027
Study endsMay 2028
Registry record updatedJune 4, 2026
Trial IDNCT06034405 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 50 and older who have had spinal decompressive surgery within the last 20 years.

Probably not a fit

Patients with confirmed primary or secondary amyloidosis or known TTR amyloidosis will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify older adults who have undergone lumbar spinal stenosis surgery and may have transthyretin cardiac amyloidosis (ATTR-CA). By analyzing spinal specimens for amyloid deposits, the study seeks to evaluate the prevalence of ATTR-CA and explore the use of artificial intelligence in identifying amyloid histologically. Participants will undergo various diagnostic tests, including nuclear scintigraphy and echocardiograms, to assess the presence of clinical manifestations of ATTR-CA. The study will be conducted at multiple prestigious medical centers, with a focus on early identification of this condition to facilitate timely treatment.

Why it matters

Potential benefit: If successful, this study could lead to earlier diagnosis and treatment of transthyretin cardiac amyloidosis in older adults, improving patient outcomes.

How similar studies have gone: While the approach of using spinal specimens to identify cardiac amyloidosis is innovative, similar studies have shown promise in identifying amyloid deposits in other contexts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Clinically indicated spinal decompressive surgery within 20 years prior to enrollment.
2. Age ≥50 years at the time of the surgery.
3. Able to understand and sign the informed consent document after the nature of the study has been fully explained.

Exclusion Criteria:

The presence of any of the following excludes eligibility for enrollment in this study:

1. Confirmed primary amyloidosis (AL) or secondary amyloidosis (AA).
2. Known TTR amyloidosis.
3. Other reason that would make the subject inappropriate for entry into this study.

Where it's running

  • Cedars-Sinai Medical Center
    Beverly Hills, California, United States
    Recruiting
  • Tufts Medical Center
    Boston, Massachusetts, United States
    Recruiting
  • Boston Medical Center
    Boston, Massachusetts, United States
    Recruiting
  • Columbia University Irving Medical Center
    New York, New York, United States
    Recruiting
  • Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting
  • Mayo Clinic
    Rochester, Minnesota, United States
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.